1-109250113-A-ACGCCGC
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM4BS2
The NM_001408.3(CELSR2):c.44_49dupCGCCGC(p.Pro15_Pro16dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000911 in 1,514,808 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.00011 ( 1 hom., cov: 0)
Exomes 𝑓: 0.000089 ( 0 hom. )
Consequence
CELSR2
NM_001408.3 disruptive_inframe_insertion
NM_001408.3 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.00700
Genes affected
CELSR2 (HGNC:3231): (cadherin EGF LAG seven-pass G-type receptor 2) The protein encoded by this gene is a member of the flamingo subfamily, part of the cadherin superfamily. The flamingo subfamily consists of nonclassic-type cadherins; a subpopulation that does not interact with catenins. The flamingo cadherins are located at the plasma membrane and have nine cadherin domains, seven epidermal growth factor-like repeats and two laminin A G-type repeats in their ectodomain. They also have seven transmembrane domains, a characteristic unique to this subfamily. It is postulated that these proteins are receptors involved in contact-mediated communication, with cadherin domains acting as homophilic binding regions and the EGF-like domains involved in cell adhesion and receptor-ligand interactions. The specific function of this particular member has not been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_001408.3.
BS2
High AC in GnomAd4 at 17 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CELSR2 | NM_001408.3 | c.44_49dupCGCCGC | p.Pro15_Pro16dup | disruptive_inframe_insertion | 1/34 | ENST00000271332.4 | NP_001399.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CELSR2 | ENST00000271332.4 | c.44_49dupCGCCGC | p.Pro15_Pro16dup | disruptive_inframe_insertion | 1/34 | 1 | NM_001408.3 | ENSP00000271332.3 |
Frequencies
GnomAD3 genomes AF: 0.000113 AC: 17AN: 150776Hom.: 1 Cov.: 0
GnomAD3 genomes
AF:
AC:
17
AN:
150776
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000989 AC: 17AN: 171874Hom.: 0 AF XY: 0.0000715 AC XY: 7AN XY: 97928
GnomAD3 exomes
AF:
AC:
17
AN:
171874
Hom.:
AF XY:
AC XY:
7
AN XY:
97928
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000887 AC: 121AN: 1363922Hom.: 0 Cov.: 60 AF XY: 0.0000856 AC XY: 58AN XY: 677614
GnomAD4 exome
AF:
AC:
121
AN:
1363922
Hom.:
Cov.:
60
AF XY:
AC XY:
58
AN XY:
677614
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000113 AC: 17AN: 150886Hom.: 1 Cov.: 0 AF XY: 0.000122 AC XY: 9AN XY: 73680
GnomAD4 genome
AF:
AC:
17
AN:
150886
Hom.:
Cov.:
0
AF XY:
AC XY:
9
AN XY:
73680
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 14, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with CELSR2-related conditions. This variant is present in population databases (rs144034706, gnomAD 0.03%). This variant, c.44_49dup, results in the insertion of 2 amino acid(s) of the CELSR2 protein (p.Pro15_Pro16dup), but otherwise preserves the integrity of the reading frame. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at